Introduction of a new drug to the market is a challenging and resource-consuming process. Predictive models developed with the use of artificial intelligence could be the solution to the growing need for an efficient tool which brings practical and knowledge benefits, but requires a large amount of high-quality data. The aim of our project was to develop quantitative structure–activity relationship (QSAR) model predicting serotonergic activity toward the 5-HT1A receptor on the basis of a created database. The dataset was obtained using ZINC and ChEMBL databases. It contained 9440 unique compounds, yielding the largest available database of 5-HT1A ligands with specified pKi value to date. Furthermore, the predictive model was developed using...
Recently developed multi-targeted ligands are novel drug candidates able to interact with monoamine ...
A three-dimensional quantitative structure - activity relationship study (3D QSAR) has been successf...
This study explores a new approach to pharmacophore screening involving the use of an optimized line...
The drug discovery and development process requires a lot of time, financial, and workforce resource...
ABSTRACT: The 5-hydroxytryptamine 1A (5-HT1A) serotonin receptor has been an attractive target for t...
The serotonin type-6 receptor (5-HT6) is a drug target for psychotic diseases, especially cognitive ...
The 5-hydroxytryptamine 1A (5-HT1A) serotonin receptor has been an attractive target for treating mo...
The 5-hydroxytryptamine 1A (5-HT<sub>1A</sub>) serotonin receptor has been an attractive target for ...
Arylpiperazine compounds are promising 5-HT1A receptor ligands that can contribute for accelerating ...
This study explores a new approach to pharmacophore screening involving the use of an optimized line...
The pharmacologically characterized receptor subtype of the serotonin family, the 5HT1A receptor is ...
Creation of a statistically reliable 3D-QSAR (Quantitative Structure Activity Relationships) model e...
In the present work, the support vector machine (SVM) and Adaboost-SVM have been used to develop a c...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Recent advances in High Throughput Screening (HTS) led to the rapid growth of chemical libraries of ...
Recently developed multi-targeted ligands are novel drug candidates able to interact with monoamine ...
A three-dimensional quantitative structure - activity relationship study (3D QSAR) has been successf...
This study explores a new approach to pharmacophore screening involving the use of an optimized line...
The drug discovery and development process requires a lot of time, financial, and workforce resource...
ABSTRACT: The 5-hydroxytryptamine 1A (5-HT1A) serotonin receptor has been an attractive target for t...
The serotonin type-6 receptor (5-HT6) is a drug target for psychotic diseases, especially cognitive ...
The 5-hydroxytryptamine 1A (5-HT1A) serotonin receptor has been an attractive target for treating mo...
The 5-hydroxytryptamine 1A (5-HT<sub>1A</sub>) serotonin receptor has been an attractive target for ...
Arylpiperazine compounds are promising 5-HT1A receptor ligands that can contribute for accelerating ...
This study explores a new approach to pharmacophore screening involving the use of an optimized line...
The pharmacologically characterized receptor subtype of the serotonin family, the 5HT1A receptor is ...
Creation of a statistically reliable 3D-QSAR (Quantitative Structure Activity Relationships) model e...
In the present work, the support vector machine (SVM) and Adaboost-SVM have been used to develop a c...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Recent advances in High Throughput Screening (HTS) led to the rapid growth of chemical libraries of ...
Recently developed multi-targeted ligands are novel drug candidates able to interact with monoamine ...
A three-dimensional quantitative structure - activity relationship study (3D QSAR) has been successf...
This study explores a new approach to pharmacophore screening involving the use of an optimized line...